Detection techniques of selective forwarding attacks in wireless sensor networks: a survey

The wireless sensor network has become a hot research area due its wide range of application in military and civilian domain, but as it uses wireless media for communication these are easily prone to security attacks. There are number of attacks on wireless sensor networks like black hole attack, sink hole attack, Sybil attack, selective forwarding attacks etc. in this paper we will concentrate on selective forwarding attacks In selective forwarding attacks, malicious nodes behave like normal nodes and selectively drop packets. The selection of dropping nodes may be random. Identifying such attacks is very difficult and sometimes impossible. In this paper we have listed up some detection techniques, which have been proposed by different researcher in recent years, there we also have tabular representation of qualitative analysis of detection techniquesComment: 6 Page

Vulnerabilities for Reactive Routing in Mobile Adhoc Networks

Mobile ad hoc network got outstanding success as well as tremendous attention due to its self -maintenance and self-configuration properties or behavior. This paper presents the area of wireless network i.e. work on ad-hoc network. This paper presents protocols of routing and their classification and their comparison. This paper also presents security issues of wireless network. This paper provides an overview of the security issues in MANETs. It classifies the attacks that are possible against the existing routing protocols. An understanding of these attacks and their impacts on the routing mechanism will help researchers in designing secure routing protocols. Keywords: MANET, AODV, DSR, FLOODING

A REVIEW OF SELECTIVE FORWARDING ATTACKS IN WIRELESS SENSOR NETWORKS

ABSTRAC

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Applying Genetic Algorithm in Intrusion Detection System: A Comprehensive Review

Abstract — Information Systems and Networks are subjected to electronic attacks. When network attacks hit, organizations are thrown into crisis mode. From the IT department to call centers, to the board room and beyond, all are fraught with danger until the situation is under control. Traditional methods which are used to overcome these threats (e.g. firewall, antivirus software, password protection etc.) do not provide complete security to the system. This encourages the researchers to develop an Intrusion Detection System which is capable of detecting and responding to such events. This review paper presents a comprehensive study of Genetic Algorithm (GA) based Intrusion Detection System (IDS). It provides a brief overview of rule-based IDS, elaborates the implementation issues of Genetic Algorithm and also presents a comparative analysis of existing studies